Shionogi

Shionogi is one of the...

• Forbes Global 2000 (#1359);
• Nikkei 225;
• Topix.

Shionogi is a company listed under the stock ticker 4507 (JP).

Shionogi has a direct presence in 3 countries.

View the org chart displaying its 34 main executives

Most searched biographies at Shionogi

• Isao Teshirogi, President, Chief Executive Officer and Director
• Keiichi Ando, Independent Non-Executive Director
• Hiroshi Ozaki, Director

Create your alert
to follow the executive moves at Shionogi.

Shionogi has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Shionogi

Social media about Shionogi

• Shionogi on Wikipedia, Google News & Yahoo Finance
• Shionogi on LinkedIn, Twitter & YouTube

Contact by email its executives including Isao Teshirogi

Call Shionogi at +81 66...

View the org chart

Register to receive your alert

Report an error